459 related articles for article (PubMed ID: 28526240)
1. Endocrine actions of vitamin D in skin: Relevance for photocarcinogenesis of non-melanoma skin cancer, and beyond.
Reichrath J; Saternus R; Vogt T
Mol Cell Endocrinol; 2017 Sep; 453():96-102. PubMed ID: 28526240
[TBL] [Abstract][Full Text] [Related]
2. Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook.
Reichrath J; Zouboulis CC; Vogt T; Holick MF
Rev Endocr Metab Disord; 2016 Sep; 17(3):405-417. PubMed ID: 27447175
[TBL] [Abstract][Full Text] [Related]
3. Challenge and perspective: the relevance of ultraviolet (UV) radiation and the vitamin D endocrine system (VDES) for psoriasis and other inflammatory skin diseases.
Reichrath J; Saternus R; Vogt T
Photochem Photobiol Sci; 2017 Mar; 16(3):433-444. PubMed ID: 28054069
[TBL] [Abstract][Full Text] [Related]
4. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells.
Reichrath J; Rech M; Moeini M; Meese E; Tilgen W; Seifert M
Cancer Biol Ther; 2007 Jan; 6(1):48-55. PubMed ID: 17172823
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE; Hutchinson PE
Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
[TBL] [Abstract][Full Text] [Related]
6. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
Reichrath J; Rass K
Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk Between Vitamin D and p53 Signaling in Cancer: An Update.
Reichrath J; Reichrath S; Vogt T; Römer K
Adv Exp Med Biol; 2020; 1268():307-318. PubMed ID: 32918225
[TBL] [Abstract][Full Text] [Related]
8. Protection from ultraviolet damage and photocarcinogenesis by vitamin D compounds.
Gordon-Thomson C; Tongkao-on W; Song EJ; Carter SE; Dixon KM; Mason RS
Adv Exp Med Biol; 2014; 810():303-28. PubMed ID: 25207373
[TBL] [Abstract][Full Text] [Related]
9. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk of Aryl Hydrocarbon Receptor (AHR)- and Vitamin D Receptor (VDR)-signaling in Human Keratinocytes.
Christofi C; Lamnis L; Stark A; Palm H; Römer K; Vogt T; Reichrath J
Anticancer Res; 2022 Oct; 42(10):5049-5067. PubMed ID: 36191995
[TBL] [Abstract][Full Text] [Related]
11. The vitamin D receptor: a tumor suppressor in skin.
Bikle DD
Adv Exp Med Biol; 2014; 810():282-302. PubMed ID: 25207372
[TBL] [Abstract][Full Text] [Related]
12. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
13. The Role of Classical and Novel Forms of Vitamin D in the Pathogenesis and Progression of Nonmelanoma Skin Cancers.
Slominski AT; Brożyna AA; Zmijewski MA; Janjetovic Z; Kim TK; Slominski RM; Tuckey RC; Mason RS; Jetten AM; Guroji P; Reichrath J; Elmets C; Athar M
Adv Exp Med Biol; 2020; 1268():257-283. PubMed ID: 32918223
[TBL] [Abstract][Full Text] [Related]
14. Cytochromes p450 and skin cancer: role of local endocrine pathways.
Slominski AT; Zmijewski MA; Semak I; Zbytek B; Pisarchik A; Li W; Zjawiony J; Tuckey RC
Anticancer Agents Med Chem; 2014 Jan; 14(1):77-96. PubMed ID: 23869782
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.
Slominski AT; Brożyna AA; Zmijewski MA; Jóźwicki W; Jetten AM; Mason RS; Tuckey RC; Elmets CA
Lab Invest; 2017 Jun; 97(6):706-724. PubMed ID: 28218743
[TBL] [Abstract][Full Text] [Related]
16. Hope and challenge: the importance of ultraviolet (UV) radiation for cutaneous vitamin D synthesis and skin cancer.
Reichrath J; Reichrath S
Scand J Clin Lab Invest Suppl; 2012; 243():112-9. PubMed ID: 22536771
[TBL] [Abstract][Full Text] [Related]
17. 1α,25(OH)₂-vitamin D and a nongenomic vitamin D analogue inhibit ultraviolet radiation-induced skin carcinogenesis.
Dixon KM; Norman AW; Sequeira VB; Mohan R; Rybchyn MS; Reeve VE; Halliday GM; Mason RS
Cancer Prev Res (Phila); 2011 Sep; 4(9):1485-94. PubMed ID: 21733837
[TBL] [Abstract][Full Text] [Related]
18. The endocrine vitamin D system in the gut.
Barbáchano A; Fernández-Barral A; Ferrer-Mayorga G; Costales-Carrera A; Larriba MJ; Muñoz A
Mol Cell Endocrinol; 2017 Sep; 453():79-87. PubMed ID: 27913273
[TBL] [Abstract][Full Text] [Related]
19. The Vitamin D Receptor as Tumor Suppressor in Skin.
Bikle DD
Adv Exp Med Biol; 2020; 1268():285-306. PubMed ID: 32918224
[TBL] [Abstract][Full Text] [Related]
20. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
Kaufmann M; Lee SM; Pike JW; Jones G
Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
